Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 2 |
NetGPI | no | yes: 0, no: 2 |
Related structures:
AlphaFold database: E9B5L8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.730 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.750 |
CLV_PCSK_KEX2_1 | 198 | 200 | PF00082 | 0.658 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.657 |
CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.781 |
CLV_PCSK_PC1ET2_1 | 198 | 200 | PF00082 | 0.658 |
CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.657 |
CLV_PCSK_PC1ET2_1 | 8 | 10 | PF00082 | 0.781 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.612 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.442 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.650 |
DEG_SPOP_SBC_1 | 157 | 161 | PF00917 | 0.543 |
DOC_CKS1_1 | 39 | 44 | PF01111 | 0.572 |
DOC_MAPK_gen_1 | 19 | 29 | PF00069 | 0.567 |
DOC_MAPK_gen_1 | 198 | 204 | PF00069 | 0.517 |
DOC_MAPK_JIP1_4 | 84 | 90 | PF00069 | 0.543 |
DOC_MAPK_MEF2A_6 | 65 | 73 | PF00069 | 0.567 |
DOC_MAPK_MEF2A_6 | 84 | 93 | PF00069 | 0.406 |
DOC_PP4_FxxP_1 | 125 | 128 | PF00568 | 0.639 |
DOC_SPAK_OSR1_1 | 9 | 13 | PF12202 | 0.613 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.735 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.568 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.569 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.518 |
LIG_14-3-3_CanoR_1 | 132 | 140 | PF00244 | 0.725 |
LIG_14-3-3_CanoR_1 | 19 | 25 | PF00244 | 0.567 |
LIG_14-3-3_CanoR_1 | 199 | 203 | PF00244 | 0.651 |
LIG_14-3-3_CanoR_1 | 84 | 89 | PF00244 | 0.628 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.561 |
LIG_BRCT_BRCA1_1 | 167 | 171 | PF00533 | 0.637 |
LIG_BRCT_BRCA1_1 | 187 | 191 | PF00533 | 0.309 |
LIG_BRCT_BRCA1_1 | 6 | 10 | PF00533 | 0.605 |
LIG_BRCT_BRCA1_1 | 73 | 77 | PF00533 | 0.525 |
LIG_BRCT_BRCA1_2 | 187 | 193 | PF00533 | 0.467 |
LIG_eIF4E_1 | 83 | 89 | PF01652 | 0.546 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.560 |
LIG_FHA_2 | 210 | 216 | PF00498 | 0.600 |
LIG_LIR_Gen_1 | 201 | 211 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 219 | 224 | PF02991 | 0.363 |
LIG_MYND_1 | 35 | 39 | PF01753 | 0.563 |
LIG_PCNA_PIPBox_1 | 70 | 79 | PF02747 | 0.538 |
LIG_PCNA_yPIPBox_3 | 65 | 77 | PF02747 | 0.554 |
LIG_SH2_CRK | 181 | 185 | PF00017 | 0.611 |
LIG_SH2_CRK | 221 | 225 | PF00017 | 0.617 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.539 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.731 |
LIG_SH3_2 | 39 | 44 | PF14604 | 0.572 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.567 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.740 |
LIG_SUMO_SIM_anti_2 | 138 | 145 | PF11976 | 0.643 |
LIG_SUMO_SIM_anti_2 | 87 | 92 | PF11976 | 0.533 |
LIG_TYR_ITIM | 179 | 184 | PF00017 | 0.605 |
LIG_TYR_ITIM | 90 | 95 | PF00017 | 0.535 |
LIG_TYR_ITSM | 217 | 224 | PF00017 | 0.652 |
LIG_WRPW_2 | 83 | 86 | PF00400 | 0.555 |
MOD_CDK_SPxK_1 | 38 | 44 | PF00069 | 0.568 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.588 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.642 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.565 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.667 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.767 |
MOD_CK2_1 | 209 | 215 | PF00069 | 0.405 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.625 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.651 |
MOD_GlcNHglycan | 166 | 170 | PF01048 | 0.541 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.660 |
MOD_GlcNHglycan | 215 | 219 | PF01048 | 0.659 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.622 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.433 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.716 |
MOD_LATS_1 | 130 | 136 | PF00433 | 0.571 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.628 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.530 |
MOD_NEK2_2 | 17 | 22 | PF00069 | 0.568 |
MOD_PIKK_1 | 135 | 141 | PF00454 | 0.697 |
MOD_PKA_1 | 132 | 138 | PF00069 | 0.549 |
MOD_PKA_1 | 198 | 204 | PF00069 | 0.655 |
MOD_PKA_1 | 226 | 232 | PF00069 | 0.699 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.759 |
MOD_PKA_2 | 198 | 204 | PF00069 | 0.655 |
MOD_PKA_2 | 226 | 232 | PF00069 | 0.699 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.767 |
MOD_Plk_1 | 97 | 103 | PF00069 | 0.560 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.642 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.659 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.531 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.459 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.570 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.519 |
MOD_SUMO_for_1 | 192 | 195 | PF00179 | 0.721 |
MOD_SUMO_for_1 | 202 | 205 | PF00179 | 0.490 |
TRG_DiLeu_BaLyEn_6 | 41 | 46 | PF01217 | 0.570 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.573 |
TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.520 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.565 |
TRG_ENDOCYTIC_2 | 92 | 95 | PF00928 | 0.630 |
TRG_ER_diArg_1 | 132 | 134 | PF00400 | 0.580 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
Q4Q2B8 | Leishmania major | 83% | 100% |